Extra shot tested to protect vulnerable transplant patients from COVID
Disease control
Terminated
This study tested if giving a dose of the Johnson & Johnson COVID-19 vaccine could improve immune protection in kidney transplant patients. These patients often have a weaker response to standard mRNA vaccines (like Pfizer or Moderna). The trial enrolled 468 kidney transplant rec…
Phase: PHASE3 • Sponsor: Mark Stegall • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC